ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest

NATerminatedINTERVENTIONAL
Enrollment

1,653

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Heart ArrestDeath, Sudden, CardiacCardiopulmonary ResuscitationCardiac Arrest
Interventions
DEVICE

Use of an impedance threshold device (ITD) during the performance of active compression decompression CPR (ACD-CPR)

"The ITD selectively prevents the influx of unnecessary respiratory gases into the patient during the chest wall recoil phase of CPR.~The ResQPump, a hand-held device containing a suction cup, attaches to the chest and actively compresses and actively re-expands the chest during the performance of CPR."

PROCEDURE

Standard cardiopulmonary resuscitation (S-CPR)

Conventional standard cardiopulmonary resuscitation (S-CPR)

Trial Locations (7)

46202

Site 07: Indianapolis, IN, Indianapolis

48073

Site 04: Oakland & Macomb Counties, MI, Royal Oak

48106

Site 06: Washtenaw & Livingston Counties, MI, Ann Arbor

54901

Site 05: Oshkosh, WI, Oshkosh

55101

Site 01: St. Paul, MN, Saint Paul

55415

Site 02: Minneapolis, MN, Minneapolis

98225

Site 03: Whatcom County, WA, Bellingham

Sponsors
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Advanced Circulatory Systems

INDUSTRY

NCT00189423 - ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest | Biotech Hunter | Biotech Hunter